Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Audrey Gabelle

Showing results (71-80 of 171) with videos related to

Pageof 18
Sort By:
Journal of the American Geriatrics Society|January 26, 2020
Prospective Associations Between Diffusion Tensor Imaging Parameters and Frailty in Older AdultsMathieu Maltais, Philipe de Souto Barreto, Lisa Perus, et al.
Molecular Neurodegeneration|October 8, 2024
Clarifying the association of CSF Aβ, tau, BACE1, and neurogranin with AT(N) stages in Alzheimer diseaseSylvain Lehmann, Susanna Schraen-Maschke, Luc Buée, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 16, 2022
Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profilesConstance Delaby, Daniel Alcolea, Christophe Hirtz, et al.
Frontiers in Aging Neuroscience|June 13, 2018
Relevance of Aβ42/40 Ratio for Detection of Alzheimer Disease Pathology in Clinical Routine: The PLM<sub>R</sub> ScaleSylvain Lehmann, Constance Delaby, Guilaine Boursier, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 5, 2024
Association of caffeine consumption with cerebrospinal fluid biomarkers in mild cognitive impairment and Alzheimer's disease: A BALTAZAR cohort studyDavid Blum, Emeline Cailliau, Hélène Béhal, et al.
Molecular Psychiatry|June 23, 2026
Beyond amyloid and tau: synaptic and neurodegenerative biomarkers shape MCI progressionConstance Delaby, Susanna Schraen-Maschke, Claire Paquet, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 26, 2023
Precision medicine analysis of heterogeneity in individual-level treatment response to amyloid beta removal in early Alzheimer's diseaseMenglan Pang, Audrey Gabelle, Paramita Saha-Chaudhuri, et al.
Scientific Reports|August 1, 2022
The interplay between cognition, depression, anxiety, and sleep in primary Sjogren's syndrome patientsRadjiv Goulabchand, Elodie Castille, Sophie Navucet, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 31, 2022
Effect of reduction in brain amyloid levels on change in cognitive and functional decline in randomized clinical trials: An instrumental variable meta-analysisMenglan Pang, Ling Zhu, Audrey Gabelle, et al.
Neurobiology of Disease|February 19, 2013
Exacerbated CSF abnormalities in younger patients with Alzheimer's diseaseJulien Dumurgier, Audrey Gabelle, Olivier Vercruysse, et al.
Pageof 18

Showing results (71-80 of 171) with videos related to

Sort By:
Pageof 18
Journal of the American Geriatrics Society|January 26, 2020
Prospective Associations Between Diffusion Tensor Imaging Parameters and Frailty in Older AdultsMathieu Maltais, Philipe de Souto Barreto, Lisa Perus, et al.
Molecular Neurodegeneration|October 8, 2024
Clarifying the association of CSF Aβ, tau, BACE1, and neurogranin with AT(N) stages in Alzheimer diseaseSylvain Lehmann, Susanna Schraen-Maschke, Luc Buée, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|February 16, 2022
Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profilesConstance Delaby, Daniel Alcolea, Christophe Hirtz, et al.
Frontiers in Aging Neuroscience|June 13, 2018
Relevance of Aβ42/40 Ratio for Detection of Alzheimer Disease Pathology in Clinical Routine: The PLM<sub>R</sub> ScaleSylvain Lehmann, Constance Delaby, Guilaine Boursier, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 5, 2024
Association of caffeine consumption with cerebrospinal fluid biomarkers in mild cognitive impairment and Alzheimer's disease: A BALTAZAR cohort studyDavid Blum, Emeline Cailliau, Hélène Béhal, et al.
Molecular Psychiatry|June 23, 2026
Beyond amyloid and tau: synaptic and neurodegenerative biomarkers shape MCI progressionConstance Delaby, Susanna Schraen-Maschke, Claire Paquet, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 26, 2023
Precision medicine analysis of heterogeneity in individual-level treatment response to amyloid beta removal in early Alzheimer's diseaseMenglan Pang, Audrey Gabelle, Paramita Saha-Chaudhuri, et al.
Scientific Reports|August 1, 2022
The interplay between cognition, depression, anxiety, and sleep in primary Sjogren's syndrome patientsRadjiv Goulabchand, Elodie Castille, Sophie Navucet, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|August 31, 2022
Effect of reduction in brain amyloid levels on change in cognitive and functional decline in randomized clinical trials: An instrumental variable meta-analysisMenglan Pang, Ling Zhu, Audrey Gabelle, et al.
Neurobiology of Disease|February 19, 2013
Exacerbated CSF abnormalities in younger patients with Alzheimer's diseaseJulien Dumurgier, Audrey Gabelle, Olivier Vercruysse, et al.
Pageof 18